Alexion Pharmaceuticals Inc (ALXN.O)
117.21USD
1 Aug 2013
$1.02 (+0.88%)
$116.19
$117.55
$118.40
$116.44
1,233,893
1,690,628
$125.65
$81.82
About
Overall
| Beta: | 0.57 |
| Market Cap (Mil.): | $22,721.88 |
| Shares Outstanding (Mil.): | 195.56 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ALXN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 66.21 | 37.93 | 37.76 |
| EPS (TTM): | 1.75 | -- | -- |
| ROI: | 15.29 | 19.48 | 18.76 |
| ROE: | 17.73 | 20.17 | 19.59 |
Alexion shares rise after report of approach by Roche
- Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last week about a takeover.
Alexion shares rise after report of approach by Roche
July 30 - Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last week about a takeover.
UPDATE 1-Alexion valuation could choke any Roche bid
* Roche seeking financing for potential Alexion bid- sources
Alexion valuation could choke any Roche bid
* Roche seeking financing for potential Alexion bid- sources
Roche seeks financing for potential Alexion bid: sources
NEW YORK/LOS ANGELES - Swiss drugmaker Roche Holding AG is seeking financing for a potential bid for Alexion Pharmaceuticals Inc , a transaction that if successful would be the largest healthcare deal of the year, two people familiar with the matter said on Friday.
UPDATE 3-Roche seeks financing for potential Alexion bid -sources
* Alexion shares close almost 13 percent higher (Adds analyst comments)
Roche seeks financing for potential Alexion takeover -sources
NEW YORK, July 12 - Swiss drugmaker Roche Holding AG is seeking financing for a potential takeover of Alexion Pharmaceuticals Inc, two people familiar with the matter said on Friday.
BRIEF-Alexion Pharmaceuticals shares up 3.1 percent in premarket trade following results
NEW YORK, April 25 - Alexion Pharmaceuticals Inc : * Shares up 3.1 percent in premarket trade following results
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Amgen, Inc. (AMGN.OQ) | $109.45 | +1.16 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

